Results 11 to 20 of about 11,756 (178)
Infectivity of amastigotes of Trypanosoma cruzi [PDF]
The infectivity amastigotes of Trypanosoma cruzi, isolated from the supernatant of the J774G8 macrophage-like cell line infected with trypomastigotes to normal macrophages in vitro was tested. After a period of 1 h of T.
Tecia Ulisses de Carvalho +1 more
doaj +3 more sources
Peptides as a Therapeutic Alternative Against Leishmaniasis: A Scoping Review. [PDF]
This scoping review of 79 studies identified 231 antimicrobial peptides with anti‐Leishmania activity, including natural‐derived and synthetic peptides (inspired by natural sources or developed through rational design). Most were evaluated in vitro against promastigote and/or amastigote forms, with synthetic peptides showing a more promising effect ...
da Veiga Oliveira ME +3 more
europepmc +2 more sources
Thymus and Leishmania at the Crossroads: Autoimmunity and Cancer. [PDF]
Conceptual ‘Crossroads Model’ linking Leishmania, thymic infection and immune dysregulation: an integrative model is proposed in which Leishmania infection disrupts thymic architecture and stromal–thymocyte interactions. These alterations converge to promote defective tolerance, increased autoimmune risk and a microenvironment permissive to malignant ...
Barros ABB +5 more
europepmc +2 more sources
Amastigote Synapse: The Tricks of Trypanosoma cruzi Extracellular Amastigotes [PDF]
To complete its life cycle within the mammalian host, Trypanosoma cruzi, the agent of Chagas' disease, must enter cells. Trypomastigotes originating from the insect vector (metacyclic) or from infected cells (bloodstream/tissue culture-derived) are the classical infective forms of the parasite and enter mammalian cells in an actin-independent manner ...
Bonfim-Melo, Alexis +3 more
openaire +6 more sources
An axenic amastigote system for drug screening [PDF]
Currently available primary screens for selection of candidate antileishmanial compounds are not ideal. The choices include screens that are designed to closely reflect the situation in vivo but are labor-intensive and expensive (intracellular amastigotes and animal models) and screens that are designed to facilitate rapid testing of a large number of ...
H L, Callahan +3 more
openaire +2 more sources
Endocytosis and Sphingolipid Scavenging inLeishmania mexicanaAmastigotes [PDF]
Leishmaniaspecies are the causative agents of the leishmaniases, a spectrum of neglected tropical diseases. Amastigote stage parasites exist within macrophages and scavenge host factors for survival, for example,Leishmaniaspecies utilise host sphingolipid for synthesis of complex sphingolipid. In this studyL.
Ali, Hayder Z. +2 more
openaire +5 more sources
The characterization of expressed sequence tags (ESTs) generated from a cDNA library of Leishmania (Leishmania) amazonensis amastigotes is described. The sequencing of 93 clones generated new L. (L.) amazonensis ESTs from which 32% are not related to any
Luciana Girotto Gentil +4 more
doaj +1 more source
Effect of thiadiazine derivatives on intracellular amastigotes of Leishmania amazonensis
Current therapy for leishmaniasis is not satisfactory. We describe the in vitro antiproliferative effects of new thiadiazine derivatives against Leishmania amazonensis.
Lianet Monzote Fidalgo +5 more
doaj +1 more source
Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes [PDF]
Induction of a glycosylphosphatidylinositol (GPI) deficiency in Trypanosoma cruzi by the heterologous expression of Trypanosoma brucei GPI-phospholipase C (GPI-PLC) results in decreased expression of major surface proteins (N. Garg, R. L. Tarleton, and K. Mensa-Wilmot, J. Biol. Chem. 272:12482-12491, 1997).
N, Garg +3 more
openaire +2 more sources
Chagas disease, caused by the parasite Trypanosoma cruzi, is an infectious illness endemic to Latin America and still lacks an effective treatment for the chronic stage.
María Cristina Vanrell +8 more
doaj +1 more source

